The story of copyright's flagship drug presents a nuanced case for investors in the medicinal sector. While initially a phenomenal success, generating billions, the patent expiration and the subsequent entry of https://knockoff042748.blog5star.com/42155996/sildenafil-and-big-pharma-a-hazardous-bet